Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.
Corso
Alessandro
A
Lorenzi
Angela
A
Zappasodi
Patrizia
P
Invernizzi
Rosangela
R
Vanelli
Laura
L
Lazzarino
Mario
M
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D004334:Drug Administration Schedule; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology*; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide